XTL Biopharmaceuticals Ltd. American (XTLB) Total Assets by Year
XTL Biopharmaceuticals Ltd. American closed fiscal year 2025 with $166K in total assets, $420K in total liabilities and -$254K in shareholder equity. This represents a decrease of 98.1% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters XTL Biopharmaceuticals Ltd. American has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
XTLB Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2520-F | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $166K-98.1% | $8.6M+252.4% | $2.4M-42.0% | $4.2M-36.7% | $6.6M+1.8% | $6.5M-9.8% | $7.2M-15.9% | $8.6M+30.2% | $6.6M+118.3% | $3.0M | N/A |
| Total Liabilities | $420K-86.5% | $3.1M+1412.1% | $206K+10.2% | $187K-85.4% | $1.3M-55.6% | $2.9M+314.8% | $697K-46.5% | $1.3M-56.1% | $3.0M+799.1% | $330K | N/A |
| Total Equity | -$254K-104.7% | $5.4M+144.8% | $2.2M-44.5% | $4.0M-25.0% | $5.3M+47.6% | $3.6M-44.6% | $6.5M-10.4% | $7.3M+101.0% | $3.6M+34.7% | $2.7M-45.0% | $4.9M |
XTLB Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2510-K | Q1'2510-K | Q2'2410-K | Q2'2310-K | Q4'2210-K | Q2'2210-K | Q4'2110-K | Q2'2110-K | Q4'2010-K | Q2'2010-K | Q2'1910-K | Q2'1810-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.6M+252.4% | $5.8M | $2.4M-42.0% | $4.2M-36.7% | $5.8M-17.2% | $6.6M+1.8% | $7.0M | $6.5M-9.8% | N/A | $7.2M-15.9% | $8.6M+30.2% | $6.6M+118.3% |
| Total Liabilities | $3.1M+1412.1% | $5.8M | $206K+10.2% | $187K-85.4% | $194K-94.7% | $1.3M-55.6% | $3.7M | $2.9M+314.8% | N/A | $697K-46.5% | $1.3M-56.1% | $3.0M+799.1% |
| Total Equity | $5.4M+144.8% | $0 | $2.2M-44.5% | $4.0M-25.0% | $5.6M+69.5% | $5.3M+47.6% | $3.3M-41.3% | $3.6M-44.6% | $5.6M | $6.5M-10.4% | $7.3M+101.0% | $3.6M+34.7% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More XTL Biopharmaceuticals Ltd. American financials
Frequently Asked Questions
What was XTL Biopharmaceuticals Ltd. American's total assets in fiscal year 2025?
XTL Biopharmaceuticals Ltd. American closed fiscal year 2025 with $166K in total assets, $420K in total liabilities and -$254K in shareholder equity.
How fast is XTL Biopharmaceuticals Ltd. American's total assets growing?
XTL Biopharmaceuticals Ltd. American (XTLB) total assets fell by 98.1% year over year, from $8.6M to $166K in fiscal year 2025.
What was XTL Biopharmaceuticals Ltd. American's total assets in the most recent quarter?
XTL Biopharmaceuticals Ltd. American (XTLB) reported $8.6M in total assets in Q2 2025. This represents an increase of 252.4% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what XTL Biopharmaceuticals Ltd. American (XTLB) reported on that line in every period on record.